Glycans Hit the Sweet Spot in Diagnostics January 2022 Our CEO Nina Skorytchenko and other innovators in this field discussing about how Glycans can be used for early diagnostics and disease prevention. Click here to read the article.
Targeting inflammaging through glycomics Longevity technology is Daily news and insights on the fast-growth longevity market, here are articles about Targeting inflammaging through glycomics. Click here to read the article.
Introduction to Avenna In this video, we explain how our in-vitro diagnostic platform technology- GlyHealth can enhance healthcare for chronic inflammatory diseases. We explain the benefits of our biomarkers for different members of healthcare ecosystem, including clinicians and drug development companies. BACK TO MEDIA GALLERY
Immunofraility Test. Instruction video In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.
Avenna Women in Innovation video 2021 In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of …
Avenna at SEHTA Conference In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation …
WuXi HealthCare forum presentation In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease. Click here to see …
Early intervention before disease progression using Gly-Health The club tracks down the latest scientific research on the causes of aging and effects on life expectancy and keeps you abreast of the wider impacts of life extension and the consequences for society when it arrives. Here is an article about early intervention before disease progression …
Early intervention before disease progression using glyhealth Read More »
Avenna at NOAH Conference 2019 This is a recording of our presentation at this renown tech conference. Our CEO discusses the burden of chronic inflammatory diseases (CIDs) and limitations in CIDs diagnostic procedures. Additionally, this presentation explains how Avenna medical technology can reliably detect and predict future CIDs using molecular signals from …
